Multiple Sclerosis Journal · 2007 · 12 citations · 3 references
MedicineOncologyPharmacologyChemotherapyHematologic OncologyMedical OncologyChemotherapy In Hematologic MalignanciesMultiple SclerosisMultiple Sclerosis PharmacotherapyAcute Myeloid Leukemia TreatmentAcute Promyelocytic LeukemiaChronic Myeloid Leukemia TherapyMitoxantrone TherapyMultiple Sclerosis Therapy
We report the first case of chronic myeloid leukemia (CML) in a patient with multiple sclerosis (MS) diagnosed within two years of receiving mitoxantrone therapy. Previously only acute forms of leukemia particularly acute promyelocytic leukemia (APL) have been associated with mitoxantrone treatment in MS. This underscores the need for only using mitoxantrone in severe treatment-unresponsive cases of MS.
3
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS
D. Brassat, Christian Récher, E. Waubant et al. · Neurology · 2002 · 65 citations
Medicine, Oncology, Pharmacology +15
Mitoxantrone in the treatment of multiple sclerosis.
S. P Morrissey, E Le Page, Gilles Edan · PubMed · 2005 · 29 citations